person · Reporting owner

SCHULER JACK W

Disclosed activity across 9 companies

Tapewire entity: 23810
SEC CIK: 0001021412

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Accelerate Diagnostics, IncAXDX · Entity 78156	Director · 10% owner	December 03, 2024	December 03, 2024
Aspira Women's Health Inc.AWHL · Entity 7871	10% owner	June 05, 2026	June 09, 2026
BIODESIX INCBDSX · Entity 6053	10% owner · Emeritus Director	August 12, 2026	August 13, 2026
BIOLASE, INCBIOL · Entity 11470	10% owner	February 11, 2020	May 15, 2020
Neos Therapeutics, Inc.NEOS · Entity 141061	10% owner	February 17, 2017	February 17, 2017
QUIDEL CORP /DE/QDEL · Entity 126712	Director · 10% owner	May 14, 2020	May 18, 2020
STERICYCLE INCSRCL · Entity 80873	Director	April 30, 2018	May 02, 2018
YIELD10 BIOSCIENCE, INC.YTEN · Entity 88195	10% owner	December 20, 2023	May 17, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Accelerate Diagnostics, Inc

Report date December 03, 2024 · Filed December 03, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Jack W. Schuler Living Trust	8,310,388	Reported balance After 2024-12-03 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2024-12-03 · Sale · Disposed 200,000 · Balance 8,310,388 F1: Represents shares sold by the reporting person to John Patience, a member of the issuer's board of directors, in a private transaction for tax planning purposes. F2: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.
Common StockSEC Table I · non-derivative	Direct	20,225	Reported balance Holding disclosure · report date 2024-12-03 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 20,225
Common StockSEC Table I · non-derivative	IndirectBy Spouse	5,497	Reported balance Holding disclosure · report date 2024-12-03 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 5,497 F3: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares sold by the reporting person to John Patience, a member of the issuer's board of directors, in a private transaction for tax planning purposes.

F2: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.

F3: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Aspira Women's Health Inc.

Report date June 05, 2026 · Filed June 09, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Jack W. Schuler Living Trust	4,046,051	Reported balance After 2026-06-05 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-06-05 · Purchase · Acquired 222,222 · Balance 4,046,051 F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2029-06-05	IndirectBy Jack W. Schuler Living Trust	300,000	Reported balance After 2026-06-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-06-05 · Purchase · Acquired 300,000 · Balance 300,000 F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2030-09-17	IndirectBy Jack W. Schuler Living Trust	833,333	Reported balance Holding disclosure · report date 2026-06-05 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 833,333 F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.25 · Expires 2030-03-12	IndirectBy Jack W. Schuler Living Trust	1,801,265	Reported balance Holding disclosure · report date 2026-06-05 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 1,801,265 F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.13 · Expires 2029-07-26	IndirectBy Jack W. Schuler Living Trust	28,500	Reported balance Holding disclosure · report date 2026-06-05 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance 28,500 F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.13 · Expires 2029-01-26	IndirectBy Jack W. Schuler Living Trust	8,888	Reported balance Holding disclosure · report date 2026-06-05 · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · Balance 8,888 F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.
Common StockSEC Table I · non-derivative	Direct	6,536	Reported balance Holding disclosure · report date 2026-06-05 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 6,536
Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.25 · Expires 2027-07-09	Direct	6,536	Reported balance Holding disclosure · report date 2026-06-05 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 6,536

Filing footnotes · ownership attribution and instrument terms

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

BIODESIX INC

Report date August 12, 2026 · Filed August 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Jack W. Schuler Living Trust	555,810	Reported balance After 2026-08-12 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-08-12 · Purchase · Acquired 15,000 · Balance 555,810 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.
Common StockSEC Table I · non-derivative	IndirectBy Jack W. Schuler 2026 GRAT	1,800,000	Reported balance Holding disclosure · report date 2026-08-12 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 1,800,000 F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler 2026 GRAT.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler 2026 GRAT.

BIOLASE, INC

Report date February 11, 2020 · Filed May 15, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Trust	739,820	Reported balance After 2020-02-11 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2020-02-11 · Sale · Disposed 1,307,931 · Balance 739,820 F1: These figures reflect a 1-for-5 reverse stock split effected by the Issuer on May 10, 2018. F2: The Common Stock is held directly by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.
Common StockSEC Table I · non-derivative	IndirectBy Spouse	20,000	Reported balance Holding disclosure · report date 2020-02-11 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 20,000 F1: These figures reflect a 1-for-5 reverse stock split effected by the Issuer on May 10, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: These figures reflect a 1-for-5 reverse stock split effected by the Issuer on May 10, 2018.

F2: The Common Stock is held directly by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.

Neos Therapeutics, Inc.

Report date February 17, 2017 · Filed February 17, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy the Jack W Schuler Living Trust	2,338,671	Reported balance Holding disclosure · report date 2017-02-17 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 2,338,671 F1: Jack W. Schuler is the sole trustee of the Jack W Schuler Living Trust. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Jack W. Schuler is the sole trustee of the Jack W Schuler Living Trust. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

QUIDEL CORP /DE/

Report date May 14, 2020 · Filed May 18, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	3,103,249	Reported balance After 2020-05-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2020-05-14 · Exercise / conversion · Acquired 2,100 · Balance 3,103,249 F1: Reflects release of restricted stock units that were previously reported on Form 4. F2: In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse and 1,105,263 shares are held indirectly by the Schuler Family Foundation. The Reporting Person disclaims all beneficial ownership of the shares held by his spouse and the Schuler Family Foundation, except to the extent of his pecuniary interest, if any.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2020-05-14 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-05-14 · Exercise / conversion · Disposed 2,100 · Balance 0 F3: Restricted stock units convert into common stock on a one-for-one basis. F4: On May 14, 2019, the reporting person was granted 2,100 restricted stock units vesting on the first anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects release of restricted stock units that were previously reported on Form 4.

F2: In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse and 1,105,263 shares are held indirectly by the Schuler Family Foundation. The Reporting Person disclaims all beneficial ownership of the shares held by his spouse and the Schuler Family Foundation, except to the extent of his pecuniary interest, if any.

F3: Restricted stock units convert into common stock on a one-for-one basis.

F4: On May 14, 2019, the reporting person was granted 2,100 restricted stock units vesting on the first anniversary of the grant date.

STERICYCLE INC

Report date April 30, 2018 · Filed May 02, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	2,078	Reported balance After 2018-04-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2018-04-30 · Grant · Acquired 170 · Balance 2,078 F1: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

Filing footnotes · ownership attribution and instrument terms

F1: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

YIELD10 BIOSCIENCE, INC.

Report date December 20, 2023 · Filed May 17, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Jack W. Schuler Living Trust	63,789	Reported balance After 2023-12-20 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2023-12-20 · Sale · Disposed 36,000 · Balance 63,789 F1: This late filing is due to an inadvertent administrative error. F2: On May 2, 2024 the Issuer effected a 1-for-24 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities beneficially owned following the transaction reported herein has been adjusted and approximated to reflect the Reverse Stock Split. F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Filing footnotes · ownership attribution and instrument terms

F1: This late filing is due to an inadvertent administrative error.

F2: On May 2, 2024 the Issuer effected a 1-for-24 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities beneficially owned following the transaction reported herein has been adjusted and approximated to reflect the Reverse Stock Split.

F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

SOLENO THERAPEUTICS INC

Report date December 09, 2022 · Filed May 15, 2023

Section 16 reporting ended · disclosed 2023-05-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Jack W. Schuler Living Trust	36,595	Reported balance After 2022-12-09 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2022-12-09 · Sale · Disposed 10,000 · Balance 36,595 F1: This late filing is due to an inadvertent administrative error. F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Filing footnotes · ownership attribution and instrument terms

F1: This late filing is due to an inadvertent administrative error.

F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 12, 2026 Filed Aug 13, 2026 21:22 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	15,000	$24.47	$366,991.50	Disclosure SEC source: 0000905148-26-003641 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner · Emeritus Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 555,810 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
August 11, 2026 Filed Aug 12, 2026 21:55 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	13,700	$24.01	$328,910.97	Disclosure SEC source: 0000905148-26-003599 · form4.xml · nonDerivative · entry 2 SCHULER JACK W · CIK 0001021412 · 10% owner · Emeritus Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 540,810 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.965 to $24.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
August 10, 2026 Filed Aug 12, 2026 21:55 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	13,900	$24.25	$337,029.13	Disclosure SEC source: 0000905148-26-003599 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner · Emeritus Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 527,110 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.89 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Reported amounts have been adjusted to reflect (i) the transfer of 750,000 shares previously held by the Jack W. Schuler 2025 GRAT to the Jack W. Schuler Living Trust on March 25, 2026 and (ii) the transfer of 1,800,000 shares previously held by the Jack W. Schuler Living Trust to the Jack W. Schuler 2026 GRAT on April 1, 2026, each of which was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
June 05, 2026 Filed Jun 9, 2026 20:53 UTC	Aspira Women's Health Inc. AWHL · Entity 7871	PurchaseWarrant (Right to Buy) · Derivative	300,000	$0.00 Strike: $0.75	$0.00	Disclosure SEC source: 0001493152-26-027952 · ownership.xml · derivative · entry 3 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 300,000 Underlying: Common Stock, par value $0.001 · 300,000 shares Expires 2029-06-05 F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust. Read SEC document
June 05, 2026 Filed Jun 9, 2026 20:53 UTC	Aspira Women's Health Inc. AWHL · Entity 7871	PurchaseCommon Stock	222,222	$0.45	$99,999.90	Disclosure SEC source: 0001493152-26-027952 · ownership.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 4,046,051 F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust. Read SEC document
January 26, 2026 Filed Jan 27, 2026 14:29 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	20,000	$11.80	$236,064.00	Disclosure SEC source: 0000905148-26-000362 · form4.xml · nonDerivative · entry 2 SCHULER JACK W · CIK 0001021412 · 10% owner · Emeritus Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,563,210 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.56 to $11.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
January 23, 2026 Filed Jan 27, 2026 14:29 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	80,000	$11.81	$944,672.00	Disclosure SEC source: 0000905148-26-000362 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner · Emeritus Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,543,210 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.225 to $12.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
January 22, 2026 Filed Jan 26, 2026 14:28 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	82,465	$10.96	$903,560.76	Disclosure SEC source: 0000905148-26-000331 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner · Emeritus Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,463,210 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.675 to $11.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
September 19, 2025 Filed Sep 23, 2025 13:29 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	142,045	$7.04	$999,996.80	Disclosure SEC source: 0000905148-25-003392 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,380,745 F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
September 18, 2025 Filed Sep 19, 2025 14:31 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	3,056	$6.17	$18,853.99	Disclosure SEC source: 0000905148-25-003371 · form4.xml · nonDerivative · entry 2 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,238,700 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.125 to $6.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
September 17, 2025 Filed Sep 19, 2025 21:26 UTC	Aspira Women's Health Inc. AWHL · Entity 7871	PurchaseWarrant (Right to Buy) · Derivative	833,333	$0.00 Strike: $0.75	$0.00	Disclosure SEC source: 0001493152-25-014334 · ownership.xml · derivative · entry 3 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 833,333 Underlying: Common Stock, par value $0.001 · 833,333 shares Expires 2030-09-17 F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust. Read SEC document
September 17, 2025 Filed Sep 19, 2025 21:26 UTC	Aspira Women's Health Inc. AWHL · Entity 7871	PurchaseCommon Stock	1,111,111	$0.45	$499,999.95	Disclosure SEC source: 0001493152-25-014334 · ownership.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 3,823,829 F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust. Read SEC document
September 17, 2025 Filed Sep 19, 2025 14:31 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	15,317	$6.04	$92,571.35	Disclosure SEC source: 0000905148-25-003371 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,235,644 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.825 to $6.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025. F3 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
August 29, 2025 Filed Sep 3, 2025 20:42 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	3,488,372	$0.43	$1,499,999.96	Disclosure SEC source: 0000905148-25-003281 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 24,406,546 F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
May 19, 2025 Filed May 20, 2025 20:11 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	723,239	$0.34	$246,624.50	Disclosure SEC source: 0000905148-25-001861 · form4.xml · nonDerivative · entry 2 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 20,918,174 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.2997 to $0.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
May 16, 2025 Filed May 20, 2025 20:11 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	4,000,000	$0.27	$1,070,000.00	Disclosure SEC source: 0000905148-25-001861 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 20,194,935 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.2215 to $0.3397, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Reported amounts have been adjusted to reflect the transfer of 15,000,000 shares previously held by the Jack W. Schuler Living Trust to the Jack W. Schuler 2025 GRAT on January 29, 2025, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
March 06, 2025 Filed Mar 10, 2025 21:05 UTC	Aspira Women's Health Inc. AWH · Entity 7871	PurchaseSenior Secured Convertible Note due 2030 · Derivative	Not disclosed	$200,000.00 Strike: $0.25	$200,000.00	Disclosure SEC source: 0000908834-25-000098 · form4.xml · derivative · entry 3 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: Not disclosed Underlying: Common Stock · 800,000 shares Expires 2030-03-06 F2 · derivative.underlying: On March 6, 2025, the Issuer issued to the Living Trust in a private transaction a Senior Secured Convertible Note due 2030 in the principal amount of $200,000 (the "Convertible Note"). Each $0.25 principal amount of the Convertible Note is convertible by its holder at any time prior to maturity into one "Phase 1 Unit," consisting of (i) one share of Common Stock and (ii) a warrant to purchase, on the terms set forth therein, 2.25 shares of Common Stock. F2 · derivative.underlying_shares: On March 6, 2025, the Issuer issued to the Living Trust in a private transaction a Senior Secured Convertible Note due 2030 in the principal amount of $200,000 (the "Convertible Note"). Each $0.25 principal amount of the Convertible Note is convertible by its holder at any time prior to maturity into one "Phase 1 Unit," consisting of (i) one share of Common Stock and (ii) a warrant to purchase, on the terms set forth therein, 2.25 shares of Common Stock. F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust. Read SEC document
December 03, 2024 Filed Dec 3, 2024 20:46 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	SaleCommon Stock	200,000	$1.57	$314,000.00	Disclosure SEC source: 0001104659-24-125216 · tm2430099-1_4seq1.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 8,310,388 F1 · shares: Represents shares sold by the reporting person to John Patience, a member of the issuer's board of directors, in a private transaction for tax planning purposes. F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust. Read SEC document
November 21, 2024 Filed Nov 22, 2024 17:30 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	100,000	$1.23	$122,840.00	Disclosure SEC source: 0000905148-24-003258 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 31,194,935 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.225 to $1.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
November 20, 2024 Filed Nov 21, 2024 20:30 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	200,000	$1.17	$234,000.00	Disclosure SEC source: 0000905148-24-003247 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 31,094,935 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.17 to $1.175, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
November 05, 2024 Filed Nov 6, 2024 20:16 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	100,253	$1.36	$136,584.69	Disclosure SEC source: 0000905148-24-002949 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 30,894,935 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.345 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
July 09, 2024 Filed Jul 11, 2024 21:15 UTC	Aspira Women's Health Inc. AWH · Entity 7871	PurchaseWarrant (Right to Buy) · Derivative	6,536	Not disclosed Strike: $2.25	Not disclosed	Disclosure SEC source: 0000908834-24-000179 · form4.xml · derivative · entry 3 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,536 Underlying: Common Stock · 6,536 shares Expires 2027-07-09 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53. Read SEC document
July 09, 2024 Filed Jul 11, 2024 21:15 UTC	Aspira Women's Health Inc. AWH · Entity 7871	PurchaseCommon Stock	6,536	Not disclosed	Not disclosed	Disclosure SEC source: 0000908834-24-000179 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,536 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53. Read SEC document
June 28, 2024 Filed Jul 1, 2024 18:30 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	Exercise / conversionRestricted Stock Units · Derivative	4,737	$0.00	$0.00	Disclosure SEC source: 0001104659-24-076959 · tm2418614-1_4seq1.xml · derivative · entry 4 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,947 Underlying: Common Stock · 4,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F4 · derivative.exercise_date: On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024. F4 · derivative.expiration_date: On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024. Read SEC document
June 28, 2024 Filed Jul 1, 2024 18:30 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	Exercise / conversionCommon Stock	4,737	$0.00	$0.00	Disclosure SEC source: 0001104659-24-076959 · tm2418614-1_4seq1.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document
May 29, 2024 Filed May 30, 2024 16:25 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	Exercise / conversionRestricted Stock Units · Derivative	7,894	$0.00	$0.00	Disclosure SEC source: 0001104659-24-066668 · tm2415918-4_4seq1.xml · derivative · entry 4 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F4 · derivative.exercise_date: On May 29, 2023, the reporting person was granted a total of 7,894 RSUs, which vested on the first-year anniversary of the grant date. F4 · derivative.expiration_date: On May 29, 2023, the reporting person was granted a total of 7,894 RSUs, which vested on the first-year anniversary of the grant date. Read SEC document
May 29, 2024 Filed May 30, 2024 16:25 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	Exercise / conversionCommon Stock	7,894	$0.00	$0.00	Disclosure SEC source: 0001104659-24-066668 · tm2415918-4_4seq1.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. Read SEC document
May 23, 2024 Filed May 23, 2024 23:14 UTC	BIODESIX INC BDSX · Entity 6053	Exercise / conversionSeries A Non-Voting Convertible Preferred Stock · Derivative	2,174	$0.00	$0.00	Disclosure SEC source: 0000905148-24-001614 · form4.xml · derivative · entry 4 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 0 Underlying: Common Stock · 86,960 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. F1 · derivative.exercise_date: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. F1 · derivative.expiration_date: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
May 23, 2024 Filed May 23, 2024 23:14 UTC	BIODESIX INC BDSX · Entity 6053	Exercise / conversionCommon Stock	86,960	Not disclosed	Not disclosed	Disclosure SEC source: 0000905148-24-001614 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 30,794,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
May 21, 2024 Filed May 23, 2024 23:14 UTC	BIODESIX INC BDSX · Entity 6053	GrantStock Options (Right to Buy) · Derivative	37,050	$0.00 Strike: $1.57	$0.00	Disclosure SEC source: 0000905148-24-001614 · form4.xml · derivative · entry 3 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,050 Underlying: Common Stock · 37,050 shares Expires 2034-05-20 F6 · derivative.exercise_date: This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. Read SEC document
May 21, 2024 Filed May 23, 2024 23:14 UTC	BIODESIX INC BDSX · Entity 6053	GrantRestricted Stock Units · Derivative	46,686	$0.00	$0.00	Disclosure SEC source: 0000905148-24-001614 · form4.xml · derivative · entry 2 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,686 Underlying: Common Stock · 46,686 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F4 · derivative.expiration_date: These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F5 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. Read SEC document
May 20, 2024 Filed May 21, 2024 18:59 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	GrantRestricted Stock Units · Derivative	66,667	$0.00	$0.00	Disclosure SEC source: 0001104659-24-063960 · tm2415084-2_4seq1.xml · derivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,667 Underlying: Common Stock · 66,667 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F2 · derivative.exercise_date: On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the RSUs to such time that is within 30 days following the reporting person's departure from the issuer's board of directors. F2 · derivative.expiration_date: On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the RSUs to such time that is within 30 days following the reporting person's departure from the issuer's board of directors. Read SEC document
May 20, 2024 Filed May 22, 2024 19:03 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	GrantCommon Stock Warrants (right to buy) · Derivative	1,560,694	Not disclosed Strike: $1.65	Not disclosed	Disclosure SEC source: 0001104659-24-064377 · tm2415263-1_4seq1.xml · derivative · entry 4 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 2,716,763 Underlying: Common Stock · 1,560,694 shares Expires 2029-01-23 F1 · price: The reported securities are included within 1,560,694 units of the issuer (the "Units") purchased by the reporting person for $1.73 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock. F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust. Read SEC document
May 20, 2024 Filed May 22, 2024 19:03 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	GrantCommon Stock	1,560,694	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-24-064377 · tm2415263-1_4seq1.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 8,510,388 F1 · price: The reported securities are included within 1,560,694 units of the issuer (the "Units") purchased by the reporting person for $1.73 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock. F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust. Read SEC document
April 05, 2024 Filed Apr 9, 2024 23:35 UTC	BIODESIX INC BDSX · Entity 6053	GrantSeries A Non-Voting Convertible Preferred Stock · Derivative	2,174	$46.00	$100,004.00	Disclosure SEC source: 0000905148-24-001142 · form4.xml · derivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 2,174 Underlying: Common Stock · 86,960 shares Expires not disclosed F1 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F1 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F1 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F1 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
January 26, 2024 Filed Jun 18, 2024 20:12 UTC	Aspira Women's Health Inc. AWH · Entity 7871	PurchaseWarrant (Right to Buy) · Derivative	28,500	Not disclosed Strike: $4.13	Not disclosed	Disclosure SEC source: 0000908834-24-000171 · form4.xml · derivative · entry 2 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2029-07-26 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $3.50. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the securities held by the Living Trust. Read SEC document
January 26, 2024 Filed Jun 18, 2024 20:12 UTC	Aspira Women's Health Inc. AWH · Entity 7871	PurchaseCommon Stock	28,500	Not disclosed	Not disclosed	Disclosure SEC source: 0000908834-24-000171 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,912,156 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $3.50. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the securities held by the Living Trust. Read SEC document
January 23, 2024 Filed Jan 25, 2024 16:11 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	GrantCommon Stock Warrants (right to buy) · Derivative	1,156,069	Not disclosed Strike: $1.65	Not disclosed	Disclosure SEC source: 0001104659-24-006677 · tm244005-4_4seq1.xml · derivative · entry 4 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,156,069 Underlying: Common Stock · 1,156,069 shares Expires 2029-01-23 F1 · price: The reported securities are included within 1,156,069 units of the issuer (the "Units") purchased by the reporting person for $1.73 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock. F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust. Read SEC document
January 23, 2024 Filed Jan 25, 2024 16:11 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	GrantCommon Stock	1,156,069	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-24-006677 · tm244005-4_4seq1.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 6,949,694 F1 · price: The reported securities are included within 1,156,069 units of the issuer (the "Units") purchased by the reporting person for $1.73 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock. F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust. Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:18 UTC	BIODESIX INC BDSX · Entity 6053	GrantRestricted Stock Units · Derivative	105,389	$0.00	$0.00	Disclosure SEC source: 0000905148-24-000043 · form4.xml · derivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,262 Underlying: Common Stock · 105,389 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period. F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. Read SEC document
December 20, 2023 Filed May 17, 2024 19:58 UTC	YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195	SaleCommon Stock	36,000	$0.20	$7,200.00	Disclosure SEC source: 0000908834-24-000148 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 63,789 F1 · date: This late filing is due to an inadvertent administrative error. F2 · balance_after: On May 2, 2024 the Issuer effected a 1-for-24 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities beneficially owned following the transaction reported herein has been adjusted and approximated to reflect the Reverse Stock Split. F3 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
December 19, 2023 Filed Dec 20, 2023 16:13 UTC	YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195	SaleCommon Stock	36,000	$0.21	$7,430.40	Disclosure SEC source: 0000908834-23-000190 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,566,956 F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
December 08, 2023 Filed Dec 11, 2023 17:49 UTC	YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195	SaleCommon Stock	35,000	$0.24	$8,319.50	Disclosure SEC source: 0000908834-23-000181 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 1,602,956 F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
October 06, 2023 Filed Oct 7, 2023 00:04 UTC	YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195	SaleCommon Stock	37,931	$0.30	$11,447.58	Disclosure SEC source: 0000908834-23-000118 · form4.xml · nonDerivative · entry 3 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 872,956 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.30 to $0.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
October 05, 2023 Filed Oct 7, 2023 00:04 UTC	YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195	SaleCommon Stock	10,670	$0.30	$3,215.94	Disclosure SEC source: 0000908834-23-000118 · form4.xml · nonDerivative · entry 2 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 910,887 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.30 to $0.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
October 04, 2023 Filed Oct 7, 2023 00:04 UTC	YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195	SaleCommon Stock	41,399	$0.31	$12,866.81	Disclosure SEC source: 0000908834-23-000118 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 921,557 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.30 to $0.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
August 23, 2023 Filed Aug 23, 2023 22:56 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	87,500	$1.71	$149,240.00	Disclosure SEC source: 0000905148-23-000785 · form4.xml · nonDerivative · entry 3 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 30,707,722 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.665 to $1.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F4 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
August 22, 2023 Filed Aug 23, 2023 22:56 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	8,307	$1.67	$13,858.57	Disclosure SEC source: 0000905148-23-000785 · form4.xml · nonDerivative · entry 2 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 30,620,222 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F4 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
August 21, 2023 Filed Aug 23, 2023 22:56 UTC	BIODESIX INC BDSX · Entity 6053	PurchaseCommon Stock	32,556	$1.64	$53,411.37	Disclosure SEC source: 0000905148-23-000785 · form4.xml · nonDerivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 30,611,915 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. F4 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Read SEC document
August 15, 2023 Filed Oct 10, 2023 20:41 UTC	YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195	PurchaseCommon Stock Warrants · Derivative	765,000	Not disclosed Strike: $0.65	Not disclosed	Disclosure SEC source: 0000908834-23-000120 · form4.xml · derivative · entry 2 SCHULER JACK W · CIK 0001021412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Jack W. Schuler Living Trust Disclosed balance after: 765,000 Underlying: Common Stock · 765,000 shares Expires 2028-08-15 F1 · security: On August 15, 2023, the Issuer completed an offering (the "Offering"), in which the Issuer issued and sold 5,750,000 units (the "Units"), each consisting of (a) one share of Common Stock and (b) one warrant (the "Warrants") to purchase one share of Common Stock. The Units were sold at a per Unit offering price of $0.65. In the Offering, the Jack W. Schuler Living Trust (the "Living Trust") purchased 765,000 Units comprised of 765,000 shares of Common Stock and 765,000 Warrants. F1 · price: On August 15, 2023, the Issuer completed an offering (the "Offering"), in which the Issuer issued and sold 5,750,000 units (the "Units"), each consisting of (a) one share of Common Stock and (b) one warrant (the "Warrants") to purchase one share of Common Stock. The Units were sold at a per Unit offering price of $0.65. In the Offering, the Jack W. Schuler Living Trust (the "Living Trust") purchased 765,000 Units comprised of 765,000 shares of Common Stock and 765,000 Warrants. F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Living Trust, and in such capacity may be deemed to beneficially own the Common Stock and Warrants held by the Living Trust. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.